Intra-Arterial Gemcitabine vs IV Gemcitabine: Pharmacokinetic Sub-study of the TIGeR-PaC Phase 3 Clinical Trial Presented at ASCO Gastrointestinal Cancers Symposium, January 2025
https://renovorx.com/wp-content/uploads/2025/01/ASCO-GI-2025_Novelli-Agah_PK-Poster_final.pdf